Immunogenicity and Safety of Defective Vaccinia Virus Lister: Comparison with Modified Vaccinia Virus Ankara

Potent and safe vaccinia virus vectors inducing cell-mediated immunity are needed for clinical use. Replicating vaccinia viruses generally induce strong cell-mediated immunity; however, they may have severe adverse effects. As a vector for clinical use, we assessed the defective vaccinia virus syste...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Ober, B. T., Brühl, P., Schmidt, M., Wieser, V., Gritschenberger, W., Coulibaly, S., Savidis-Dacho, H., Gerencer, M., Falkner, F. G.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Microbiology 2002
Aiheet:
Gene Therapy
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC136372/
https://ncbi.nlm.nih.gov/pubmed/12097585
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.76.15.7713-7723.2002
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia